Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeting Cancer at the Nuclear Pore.

× No keyword cloud information.

9 in total

1. Nuclear export mechanisms of circular RNAs: size does matter.

Authors: Asfar S Azmi
Journal: Noncoding RNA Investig Date: 2018-09-14

2. Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC).

Authors: Misako Nagasaka; Mohammad Fahad B Asad; Mohammed Najeeb Al Hallak; Md Hafiz Uddin; Ammar Sukari; Yasmine Baca; Joanne Xiu; Dan Magee; Hirva Mamdani; Dipesh Uprety; Chul Kim; Bing Xia; Stephen V Liu; Jorge J Nieva; Gilberto Lopes; Gerold Bepler; Hossein Borghaei; Michael J Demeure; Luis E Raez; Patrick C Ma; Sonam Puri; W Michael Korn; Asfar S Azmi
Journal: Lung Cancer Date: 2021-08-27 Impact factor: 6.081

Review 3. The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma.

Authors: Mark Sellin; Stephanie Berg; Patrick Hagen; Jiwang Zhang
Journal: Transl Oncol Date: 2022-06-01 Impact factor: 4.803

Review 4. The nuclear export protein XPO1 - from biology to targeted therapy.

Authors: Asfar S Azmi; Mohammed H Uddin; Ramzi M Mohammad
Journal: Nat Rev Clin Oncol Date: 2020-11-10 Impact factor: 66.675

5. Preclinical Assessment with Clinical Validation of Selinexor with Gemcitabine and Nab-Paclitaxel for the Treatment of Pancreatic Ductal Adenocarcinoma.

Authors: Asfar S Azmi; Husain Yar Khan; Irfana Muqbil; Amro Aboukameel; Jasper E Neggers; Dirk Daelemans; Amit Mahipal; Gregory Dyson; Mandana Kamgar; Mohammad Najeeb Al-Hallak; Anteneh Tesfaye; Steve Kim; Vinod Shidham; Ramzi M Mohammad; Philip A Philip
Journal: Clin Cancer Res Date: 2019-12-12 Impact factor: 12.531

Review 6. Comprehensive landscape and future perspectives of circular RNAs in colorectal cancer.

Authors: Fei Long; Zhi Lin; Liang Li; Min Ma; Zhixing Lu; Liang Jing; Xiaorong Li; Changwei Lin
Journal: Mol Cancer Date: 2021-02-03 Impact factor: 27.401

7. Identification of Novel Covalent XPO1 Inhibitors Based on a Hybrid Virtual Screening Strategy.

Authors: Zheyuan Shen; Weihao Zhuang; Kang Li; Yu Guo; Bingxue Qu; Sikang Chen; Jian Gao; Jing Liu; Lei Xu; Xiaowu Dong; Jinxin Che; Qimeng Li
Journal: Molecules Date: 2022-04-14 Impact factor: 4.927

8. Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors.

Authors: Elham Barazeghi; Surendra Prabhawa; Olov Norlén; Per Hellman; Peter Stålberg; Gunnar Westin
Journal: BMC Cancer Date: 2018-07-25 Impact factor: 4.430

9. Targeting XPO1 and PAK4 in 8505C Anaplastic Thyroid Cancer Cells: Putative Implications for Overcoming Lenvatinib Therapy Resistance.

Authors: Husain Yar Khan; James Ge; Misako Nagasaka; Amro Aboukameel; Gabriel Mpilla; Irfana Muqbil; Mark Szlaczky; Mahmoud Chaker; Erkan Baloglu; Yosef Landesman; Ramzi M Mohammad; Asfar S Azmi; Ammar Sukari
Journal: Int J Mol Sci Date: 2019-12-29 Impact factor: 5.923

9 in total